McKesson to Acquire Rexall Health from Katz Group

“McKesson announced Wednesday its agreement to acquire Rexall Health from Katz Group for $3 billion Canadian ($2.2 billion in U.S. dollars). The acquisition is expected to strengthen McKesson’s position in Canada’s pharmaceutical supply chain, the company said, noting that the two companies have worked together for more than 20 years.” Read more at Drug Store News.